Bio-Path slides on equity offering

Bio Path Holdings

16/02/2021 14:24

** Bio-Path Holdings Inc  BPTH.O  shares down ~10% premarket
as co raises equity
    ** Cancer biotech firm offers 1.7 mln shares at $7.60,
raises $13 mln for working capital and general corporate
purposes  urn:newsml:reuters.com:*:nGNX12CKsC
    ** Offering price is ~15% discount to stock's last sale on
Fri
    ** Roth Capital sole bookrunner
    ** Last Weds, BPTH's more than doubled to close at $11.77
after co was granted third U.S. patent for DNAbilize platform
tech, its method for producing and delivering DNA therapeutics
 urn:newsml:reuters.com:*:nL4N2KG3AV
    ** Deal size is nearly 40% of BPTH's free float of shares,
per Refinitiv data

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))